Related Experiment Video
Updated: May 20, 2025

13:35
Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
Published on: March 21, 2021
10.3K
Predictive model for sarcopenia in chronic kidney disease: a nomogram and machine learning approach using CHARLS data
Renjie Lu1, Shiyun Wang2, Pinghua Chen2
1Longhua Clinical Medical College of Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Frontiers in Medicine
|March 27, 2025
Summary
This study developed a predictive model for sarcopenia in chronic kidney disease (CKD) patients using the CHARLS dataset. The Gradient Boosting Machine model demonstrated high accuracy in identifying individuals at risk, aiding clinical management.
Area of Science:
- Nephrology
- Geriatrics
- Biostatistics
Background:
- Sarcopenia is a common complication in chronic kidney disease (CKD) patients, leading to adverse clinical outcomes.
- Early identification and management of sarcopenia are crucial for improving patient prognosis in CKD.
Purpose of the Study:
- To develop and validate a predictive model for sarcopenia risk in individuals with CKD.
- To identify key predictors of sarcopenia in the CKD population using machine learning techniques.
Main Methods:
- Utilized data from the China Health and Retirement Longitudinal Study (CHARLS) with 1,092 CKD patients.
- Employed LASSO regression and logistic regression for predictor identification, constructing a nomogram for risk prediction.
- Applied machine learning algorithms, including Gradient Boosting Machine (GBM) with Bayesian optimization, for model development and validation using ROC and DCA.
Main Results:
- Identified age, waist circumference, LDL-C, HDL-C, triglycerides, and diastolic blood pressure as significant predictors of sarcopenia.
- The optimized GBM model achieved high predictive accuracy with an AUC of 0.933 in the training set and 0.932 in the validation set.
- SHAP analysis highlighted age and waist circumference as the most influential factors in sarcopenia prediction.
Conclusions:
- The developed nomogram and GBM model offer reliable tools for predicting sarcopenia risk in CKD patients.
- These models can aid clinicians in early risk assessment and effective management strategies for sarcopenia in the CKD population.

